section name header

Pronunciation

tye-oh-KON-a-zole

Classifications

Therapeutic Classification: antifungals (vaginal)

Indications

REMS


Action

  • Affects the permeability of the fungal cell wall, allowing leakage of cellular contents. Not active against bacteria.
Therapeutic effects:
  • Inhibited growth and death of susceptible Candida, with decrease in accompanying symptoms of vulvovaginitis (vaginal burning, itching, discharge).

Pharmacokinetics

Absorption: Minimal through intact skin.

Distribution: Unknown. Action is primarily local.

Metabolism/Excretion: Negligible with local application.

Half-Life: Not applicable.

Time/Action Profile

ROUTEONSETPEAKDURATION
Intravagunknownunknownunknown



Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

GU: irritation, vulvovaginal burning

Interactions

Drug-drug:

Route/Dosage

Availability

Assessment

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

1–Day, Monistat-1Day, Vagistat-1

Code

NDC Code